review Open Access
Inhibitors of mammalian G1 cyclin-dependent kinases.
Genes & Development · 1995 · Vol. 9(10) · pp. 1149–1163
Charles J. Sherr✉(St. Jude Children's Research Hospital)Joanna Roberts(St. Jude Children's Research Hospital)
Abstract
C J Sherr and J M Roberts Howard Hughes Medical Institute, Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38104, USA.
Cancer-related Molecular PathwaysMicrotubule and mitosis dynamicsUbiquitin and proteasome pathwaysBiologyKinaseCyclin-dependent kinaseCell biologyProtein-Serine-Threonine KinasesCyclinCell cycleCancer researchBiochemistryProtein kinase A
MeSH terms
AnimalsCarrier ProteinsCell CycleCell DifferentiationDNA RepairFungal ProteinsGenesHistone DeacetylasesHumansMammalsMicrotubule-Associated ProteinsRepressor ProteinsTranscription FactorsTumor Suppressor Protein p53Cyclins
Citations
3,256
FWCI
—
field-weighted impact
References
154
Percentile
—
vs. same field & year
Citations per year
Cited by
New functional activities for the p21 family of CDK inhibitors.
Genes & Development · 1997 · 1,411 citations
MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-XL, and Mcl-1 and promotes survival of human pancreatic cancer cells
Journal of Cellular Biochemistry · 2000 · 411 citations
Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy
Journal of Dental Research · 2008 · 518 citations
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Genes & Development · 1998 · 2,108 citations
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
Cell · 1997 · 5,018 citations
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
Oncogene · 2008 · 849 citations
CDK inhibitors: positive and negative regulators of G1-phase progression
Genes & Development · 1999 · 6,077 citations
The p21Cip1 and p27Kip1 CDK `inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
The EMBO Journal · 1999 · 1,141 citations
References
D-type cyclin-dependent kinase activity in mammalian cells.
Molecular and Cellular Biology · 1994 · 1,055 citations
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
Genes & Development · 1994 · 1,972 citations
Inhibition of cyclin-dependent kinases by p21.
Molecular Biology of the Cell · 1995 · 1,018 citations
Cloning of Senescent Cell-Derived Inhibitors of DNA Synthesis Using an Expression Screen
Experimental Cell Research · 1994 · 1,347 citations
WAF1, a potential mediator of p53 tumor suppression
Cell · 1993 · 8,369 citations
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
Cell · 1993 · 5,653 citations
Cyclin D1 is a nuclear protein required for cell cycle progression in G1.
Genes & Development · 1993 · 1,627 citations
Human Cyclin E, a Nuclear Protein Essential for the G<sub>1</sub>-to-S Phase Transition
Molecular and Cellular Biology · 1995 · 1,136 citations
Related articles
Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors
Cancers · 2015 · 340 citations
The p21Cip1 and p27Kip1 CDK `inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
The EMBO Journal · 1999 · 1,141 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.